Partner Therapeutics, Inc. (PTx) Closes $60 Million Financing

Funds to support pipeline development and commercial operations 

BOSTON, MA – February 1, 2018/ PR Newswire/

Partner Therapeutics, Inc. (PTx) announced today the closing of a Series A financing to support the launch and growth of the company. PTx is an oncology company focused on the development and commercialization of approved and late-stage therapies that improve treatment outcomes and reduce the total cost of care.

The financing totaled $60 million and was led by a group of pre-eminent biopharma investors, including Perceptive Advisors, ...

Continue Reading →
0

BioPharma Veterans Launch New Oncology Company

Partner Therapeutics to focus on commercial and late-stage cancer therapies.

BOSTON, Jan. 25, 2018-PRNewswire

Biotech and pharmaceutical executives Robert Mulroy and Dr. Debasish Roychowdhury announced today the launch of Partner Therapeutics, or PTx, an oncology company that is focused on the development and commercialization of approved and late-stage therapies. The Boston-area company is committed to supporting patient care with medicines that improve cancer treatment outcomes and reduce the total cost of care.

Mr. Mulroy and Dr. Roychowdhury are biopharma veterans who combined have ...

Continue Reading →
0
Page 4 of 4 1234